Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women

被引:225
作者
Wald, A
Langenberg, AGM
Link, K
Izu, AE
Ashley, R
Warren, T
Tyring, S
Douglas, JM
Corey, L
机构
[1] Univ Washington, Virol Res Clin, Dept Med, Seattle, WA 98122 USA
[2] Univ Washington, Dept Epidemiol, Seattle, WA 98122 USA
[3] Univ Washington, Dept Lab Med, Seattle, WA 98122 USA
[4] Chiron Corp, Emeryville, CA 94608 USA
[5] Univ Texas, Med Branch, Dept Microbiol, Galveston, TX 77550 USA
[6] Univ Texas, Med Branch, Dept Immunol, Galveston, TX 77550 USA
[7] Univ Texas, Med Branch, Dept Dermatol, Galveston, TX 77550 USA
[8] Univ Texas, Med Branch, Dept Pediat, Galveston, TX 77550 USA
[9] Dept Publ Hlth, Denver, CO USA
[10] Fred Hutchinson Canc Res Ctr, Program Infect Dis, Seattle, WA 98104 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2001年 / 285卷 / 24期
关键词
D O I
10.1001/jama.285.24.3100
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Herpes simplex virus type 2 (HSV-2) is one of the most common sexually transmitted infections in the United States. No prospective study has shown the ability of condoms to reduce transmission of HSV-2. Objective To evaluate risk factors for HSV-2 acquisition and efficacy of condoms in prevention of HSV-2 transmission. Design Analysis of data from a randomized, double-blind, placebo-controlled trial conducted December 13, 1993, to June 28, 1996, of an ineffective candidate HSV-2 vaccine with 18 months of follow-up. Setting Eighteen clinical trial centers in the United States. Participants A total of 528 monogamous couples discordant for HSV-2 infection, including an HSV-2- susceptible population of 261 men and 267 women. Main Outcome Measure Acquisition of HSV-2 infection by susceptible partners, compared with those remaining free of HSV-2 with regard to demographic characteristics, sexual activity, and condom use. Results Twenty-six women (9.7%) vs 5 men (1.9%) acquired HSV-2, for a rate per 10000 sex acts (episodes of sexual intercourse) of 8.9 vs 1.5, respectively (P<.001). In multivariable analysis, younger age (adjusted hazard ratio [HR] per 5 years, 1.57; 95% confidence interval [Cl], 1.22-2.04), seropositivity for HSV-1 and HSV-2 vs HSV-2 alone in the source partner (adjusted HR, 2.34; 95% Cl, 1.14-4.82), and more frequent sexual activity (adjusted HR per additional sex act per week, 1.10; 95% Cl, 1.01-1.19) were associated with higher risk of HSV-2 acquisition. Condom use during more than 25% of sex acts was associated with protection against HSV-2 acquisition for women (adjusted HR, 0.085; 95% Cl, 0.01-0.67) but not for men (adjusted HR, 2.02; 95% Cl, 0.32-12.50). Risk of HSV-2 transmission declined from 8.5 per 100 person-years in the initial 150-day interval to 0.9 per 100 person-years in the final 150-day interval (P=.002 for trend), concurrent with a decrease in sexual activity and proportion of sex acts occurring when the source partner had genital lesions. Conclusions Condom use offers significant protection against HSV-2 infection in susceptible women. Changes in sexual behavior, correlated with counseling about avoiding sex when a partner has lesions, were associated with reduction in HSV-2 acquisition over time. These data suggest that identification of discordant couples can reduce transmission of HSV-2, especially for heterosexual couples in which the male partner has HSV-2 infection.
引用
收藏
页码:3100 / 3106
页数:7
相关论文
共 33 条
[11]   PREVALENCE OF AIDS-RELATED RISK-FACTORS AND CONDOM USE IN THE UNITED-STATES [J].
CATANIA, JA ;
COATES, TJ ;
STALL, R ;
TURNER, H ;
PETERSON, J ;
HEARST, N ;
DOLCINI, MM ;
HUDES, E ;
GAGNON, J ;
WILEY, J ;
GROVES, R .
SCIENCE, 1992, 258 (5085) :1101-1106
[12]   Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection - Two randomized controlled trials [J].
Corey, L ;
Langenberg, AGM ;
Ashley, R ;
Sekulovich, RE ;
Izu, AE ;
Douglas, JM ;
Handsfield, HH ;
Warren, T ;
Marr, L ;
Tyring, S ;
DiCarlo, R ;
Adimora, AA ;
Leone, P ;
Dekker, CL ;
Burke, RL ;
Leong, WP ;
Straus, SE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (04) :331-340
[14]   Probability of heterosexual transmission of HIV: Relationship to the number of unprotected sexual contacts [J].
Downs, AM ;
DeVincenzi, I ;
Costigliola, P ;
Ricchi, E ;
Chiodo, F ;
Roumeliotou, A ;
Papaevangelou, G ;
Coutinho, RA ;
vanHaastrecht, HJA ;
Brettle, R ;
Robertson, R ;
Kraus, M ;
Heckmann, W ;
Saracco, A ;
Sacco, OL ;
Johnson, AM ;
Vandenbruaene, M ;
Goeman, J ;
Cardoso, J ;
Sobel, A ;
GonzalezLahoz, J ;
AndresMedina, R ;
Casabona, J ;
Tor, J ;
AncellePark, RA ;
Brunet, JB .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 11 (04) :388-395
[15]   Herpes simplex virus type 2 in the United States, 1976 TO 1994 [J].
Fleming, DT ;
McQuillan, GM ;
Johnson, RE ;
Nahmias, AJ ;
Aral, SO ;
Lee, FK ;
StLouis, ME .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (16) :1105-1111
[16]  
*KAIS FAM FDN, 1998, SEX TRANSM DIS AM MA
[17]   DIAGNOSIS OF HERPES-SIMPLEX VIRUS BY DIRECT IMMUNOFLUORESCENCE AND VIRAL ISOLATION FROM SAMPLES OF EXTERNAL GENITAL LESIONS IN A HIGH-PREVALENCE POPULATION [J].
LAFFERTY, WE ;
KROFFT, S ;
REMINGTON, M ;
GIDDINGS, R ;
WINTER, C ;
CENT, A ;
COREY, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (02) :323-326
[18]   COMPARISON OF DIPLOID FIBROBLAST AND RABBIT KIDNEY TISSUE-CULTURES AND A DIPLOID FIBROBLAST MICROTITER PLATE SYSTEM FOR THE ISOLATION OF HERPES-SIMPLEX VIRUS [J].
LANGENBERG, A ;
ZBANYSZEK, R ;
DRAGAVON, J ;
ASHLEY, R ;
COREY, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (09) :1772-1774
[19]   A RECOMBINANT GLYCOPROTEIN VACCINE FOR HERPES-SIMPLEX TYPE-2 - SAFETY AND EFFICACY [J].
LANGENBERG, AGM ;
BURKE, RL ;
ADAIR, SF ;
SEKULOVICH, O ;
TIGGES, M ;
DEKKER, CL ;
COREY, L .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (12) :889-898
[20]   HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) NEF-SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN NONINFECTED HETEROSEXUAL CONTACT OF HIV-INFECTED PATIENTS [J].
LANGLADEDEMOYEN, P ;
NGOGIANGHUONG, N ;
FERCHAL, F ;
OKSENHENDLER, E .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) :1293-1297